These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4390130)

  • 1. Metabolic effect of p-aminosalicylic acid on human erythrocytes.
    Hla Pe U; Than Batu A
    J Pharm Pharmacol; 1969 May; 21(5):330-1. PubMed ID: 4390130
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of some metabolites of hemolytic drugs on young and old, normal and G-6-PD-deficient human erythrocytes.
    Fraser IM; Tilton BE; Vesell ES
    Ann N Y Acad Sci; 1971 Jul; 179():644-53. PubMed ID: 5285395
    [No Abstract]   [Full Text] [Related]  

  • 3. A methemoglobin-dependent and plasma-stimulated experimental model of oxidative hemolysis.
    Benatti U; Morelli A; Damiani G; De Flora A
    Biochem Biophys Res Commun; 1982 Jun; 106(4):1183-90. PubMed ID: 6810891
    [No Abstract]   [Full Text] [Related]  

  • 4. The in vitro action of dapsone and its derivatives on normal and G6PD-deficient red cells.
    Scott GL; Rasbridge MR
    Br J Haematol; 1973 Mar; 24(3):307-17. PubMed ID: 4713632
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistance of erythrocytes of different ages to oxidants in persons with hereditary glucosephosphate dehydrogenase deficiency].
    Ermakova TA; Tokarev IuN; Kolodeĭ SV; Kulagin MN
    Gematol Transfuziol; 1989 Mar; 34(3):45-8. PubMed ID: 2721908
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of elevated glucose concentrations in the hemolysis of glucose-6-phosphate dehydrogenase deficient erythroycytes (38474).
    Glader BE
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):50-3. PubMed ID: 236572
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations in normal and G-6-PD deficient human erythrocytes of various ages after exposure to metabolites of hemolytic drugs.
    Fraser IM; Tilton BE; Vesell ES
    Pharmacology; 1971; 5(3):173-87. PubMed ID: 5119006
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of copper on the erythrocyte hexose monophosphate shunt pathway.
    Metz EN; Sagone AL
    J Lab Clin Med; 1972 Sep; 80(3):405-13. PubMed ID: 5055388
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of ascorbic acid on copper-induced oxidative changes in erythrocytes of individuals with a glucose-6-phosphate dehydrogenase deficiency.
    Calabrese EJ; Moore GS; McCarthy MS
    Bull Environ Contam Toxicol; 1983 Mar; 30(3):323-30. PubMed ID: 6850118
    [No Abstract]   [Full Text] [Related]  

  • 10. Presence in Vicia faba of different substances with activity in vitro on Gd(-)Med red blood cell reduced glutathione.
    Bottini E; Lucarelli P; Spennati GF; Businco L; Palmarino R
    Clin Chim Acta; 1970 Dec; 30(3):831-4. PubMed ID: 5493904
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-experimental studies on hemolysis induced in vitro by sodium parachloromercuribenzoate].
    Broccia G; Corda G; Zizi P; Pellegrini A
    G Clin Med; 1966 Oct; 47(10):1002-19. PubMed ID: 5997187
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative patterns of 'in vitro' oxidative hemolysis of normal and glucose 6-phosphate dehydrogenase (G6PD)-deficient erythrocytes.
    Benatti U; Morelli A; Meloni T; Sparatore B; Salamino F; Michetti M; Melloni E; Pontremoli S; de Flora A
    FEBS Lett; 1981 Jun; 128(2):225-9. PubMed ID: 7262314
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemolytic effect of two sulphonamides evaluated by a new method.
    Gaetani GD; Mareni C; Ravazzolo R; Salvidio E
    Br J Haematol; 1976 Feb; 32(2):183-91. PubMed ID: 1247492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte metabolism following surface induced injury.
    Bernstein EF
    Trans Am Soc Artif Intern Organs; 1971; 17():386-91. PubMed ID: 5158123
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of hemolysis in vitro for the purpose of detecting primaquine sensitivity].
    Allakhverdiev AM; Grinberg LN
    Lab Delo; 1981; (12):724-6. PubMed ID: 6172643
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of haemoglobin in the protection of reduced glutathione against destruction by 'oxidant' drugs.
    Beutler E; Mathai C
    Nature; 1965 Mar; 205(976):1121-2. PubMed ID: 5833219
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of methyl oleate ozonide, a possible ozone intermediate, on normal and G-6-PD deficient erythrocytes.
    Calabrese EJ; Moore GS; Williams P
    Bull Environ Contam Toxicol; 1982 Oct; 29(4):498-504. PubMed ID: 7171860
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced hemolysis: biochemical considerations.
    Shahidi NT
    Birth Defects Orig Artic Ser; 1970 Jun; 6(2):9-15. PubMed ID: 5522339
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of oxidized glutathione and acetylphenylhydrazine on haemoglobin from normal and glucose-6-phosphate dehydrogenase deficient individuals.
    Zaidman J
    Br J Haematol; 1970 Aug; 19(2):237-41. PubMed ID: 5453922
    [No Abstract]   [Full Text] [Related]  

  • 20. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
    Bashan N; Peleg N; Moses SW
    Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.